BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China

Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...

October 17, 2023 | News

WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing

WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...

October 17, 2023 | News

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

October 16, 2023 | News

Metabolon Introduces Liver and Kidney Panels for Disease Research

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

October 13, 2023 | News

Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma

In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...

October 11, 2023 | News

GE HealthCare Expands Human Subject Research with Stanford Medicine Using Photon Counting CTi Technology

Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...

October 10, 2023 | News

Innovent Initiates Phase 3 Study of Efdamrofusp Alfa for Age-related Macular Degeneration

nnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...

October 09, 2023 | News

GE Healthcare and University Hospitals Announce 10-Year Collaboration to Enhance Imaging and Digital Solutions

Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) today announ...

October 06, 2023 | News

Veramed expands its global footprint by acquiring Clinical Trial Data Services (CTDS)

Specialist Biometrics CRO, Veramed, announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS. The d...

October 06, 2023 | News

Wolters Kluwer unveils generative AI Labs for UpToDate

UpToDate is used by more than two million users at over 44,000 healthcare organizations in over 190 countries. Medical professionals turn to UpToDate to vi...

October 04, 2023 | News

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

October 04, 2023 | News

FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

October 04, 2023 | News

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

October 03, 2023 | News

WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy

Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...

October 02, 2023 | News

Stay Connected